Valuation: Stem Cells Spin S.A.

Market Cap	16.95M 4.48M 3.91M 3.62M 3.32M 6.28M 431M 6.39M 43.14M 211M 16.81M 16.44M 727M	P/E 2024	-15.6x	P/E 2025	-31.9x
Enterprise Value	17.03M 4.5M 3.93M 3.64M 3.34M 6.31M 433M 6.42M 43.36M 212M 16.89M 16.52M 731M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	19.04%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Stem Cells Spin S.A.

05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-16	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-14	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
14/08/24	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
14/11/23	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
14/08/23	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

More news

Managers and Directors: Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	01/01/2017

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	28/06/2022
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	15/03/2022

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	+9.63%	+2.50%	+28.12%	+2.50%	4.49M
LONZA GROUP AG	-1.07%	+0.38%	+2.06%	+5.66%	50.35B
REVOLUTION MEDICINES, INC.	-2.85%	-5.58%	+373.90%	+572.09%	39.21B
IQVIA HOLDINGS INC.	+1.78%	+3.29%	+33.49%	-4.80%	34.52B
BEONE MEDICINES AG	+1.98%	+5.15%	+17.69%	+61.68%	34.6B
CELLTRION, INC.	+0.06%	-0.57%	+3.35%	+27.42%	27.05B
ASCENDIS PHARMA A/S	-3.27%	-6.27%	-	-	16.68B
MEDPACE HOLDINGS, INC.	+1.64%	+1.11%	+72.02%	+121.18%	15.11B
EUROFINS SCIENTIFIC SE	+0.29%	+3.64%	+15.30%	+17.80%	13.85B
ICON PUBLIC LIMITED COMPANY	-1.21%	+2.74%	+16.77%	-30.96%	13.18B
Average	+0.65%	+0.98%	+62.52%	+85.84%	24.46B
Weighted average by Cap.	-0.41%	+0.70%	+79.63%	+118.91%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

08-14 - Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
14/07/26	PLN 0.4100	+9.63%	26
10/07/26	PLN 0.3740	-6.50%	1,453
08/07/26	PLN 0.4000	-0.50%	100
07/07/26	PLN 0.4020	+0.50%	5,027

End-of-day quote Warsaw S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. Other stock markets 14/07/2026			5-day change	1st Jan Change
0.4100 ^PLN	+9.63%		+2.50%	+0.99%

1 day	+9.63%
1 week	+2.50%
Current month	+2.50%
1 month	-2.38%
3 months	+5.67%
6 months	+0.99%
Current year	+0.99%

1 week	0.37	0.41
1 month	0.37	0.44
Current year	0.33	0.48
1 year	0.26	0.52
3 years	0.14	0.82
5 years	0.14	1.23
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 14.33K 12.53K 11.59K 10.63K 20.12K 1.38M 20.47K 138K 674K 53.83K 52.64K 2.33M	65.74K 17.36K 15.17K 14.03K 12.88K 24.37K 1.67M 24.79K 167K 817K 65.19K 63.75K 2.82M
Net income	-520K -137K -120K -111K -102K -193K -13.24M -196K -1.32M -6.46M -516K -505K -22.32M	-526K -139K -121K -112K -103K -195K -13.37M -198K -1.34M -6.53M -521K -510K -22.55M
Net Debt	69.28K 18.29K 15.99K 14.79K 13.57K 25.68K 1.76M 26.13K 176K 861K 68.7K 67.19K 2.97M	84.58K 22.34K 19.52K 18.05K 16.57K 31.36K 2.15M 31.9K 215K 1.05M 83.88K 82.03K 3.63M

Stem Cells Spin S.A. Stock

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation: Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news : Stem Cells Spin S.A.

Quotes and Performance

Course Extremes

Managers and Directors: Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates